REFERENCES
- Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 1999; 20: 469–473.
- Heyes MP, Brew BJ, Martin A et al. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the brain metabolite quinolinic acid. Neurosci Lett 1984; 48: 273–278.
- Heyes MR Saito K, Crowley JS et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992; 115: 1249–1273.
- Leib SL, Kim YS, Ferriero DM, Tuber MG. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. J Infect Dis 1996; 173: 166–171.
- Sanni LA, Thomas SR, Tattam BN et al. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and non-cerebral malaria. Am J Pathol 1998; 152: 611–619.
- Bianchi M, Bertini R, Ghezzi P. Induction of indoleamine dioxygenase by interferon in mice: a study of different recom-binant interferons and various cytokines. Biochem Biophys Res Commun 1988; 152: 237–242.
- Neill AL, Hunt NH. Pathology of fatal and resolving Plasmo-dium berghei cerebral malaria in mice. Parasitology 1992; 105: 165–175.
- Pfefferkorn ER. Interferon-gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984; 81: 908–912.
- Shemer Y, Kol R, Sarov I. Tryptophan reversal of recombinanthuman gamma-interferon inhibition of C. trachomatis growth. Curr Microbiol 1987; 16: 9–13.
- Thomas SR, Stocker R. Redox reactions related to the indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 1999; 4: 199–220.